The biopesticides market, valued at USD 8.22 billion in 2025, is projected to reach USD 9.00 billion in 2026 and USD 20.46 billion by 2035, representing a CAGR of 9.6% during the forecast period. The major biopesticides market growth drivers include growth in seed treatment solutions and increase in integrated pest management (IPM) for crop cultivation. Seed treatment forms a chemical barrier between the seed and the external environment, protecting the seed and enhancing plant vigor. Presently,...

The global skincare market size is projected to grow from US$184 billion in 2024 to US$407 billion by 2035, representing a CAGR of 7.5%, during the forecast period, till 2035. The skincare industry is a dynamic and rapidly evolving sector that plays a crucial role in enhancing the health and appearance of skin for consumers worldwide. Since 1970s, technological advancements in terms of manufacturing capabilities, advanced product formulators and customer relationship management tools have propel...

The global SARM1 inhibitor market size is estimated to be worth USD 5 million in 2033 and is expected to reach USD 727 million by 2040, growing at a CAGR of 102% during the forecast period. According to a United Nations report, nearly 1 billion people around the world suffer from various neurological conditions. Further a WHO report states that the U.S. alone spends more than USD 655 billion every year on neurological disorders. Consequently, the rising incidence of neurological disorders has ex...

The global conjugation and labeling services market, valued at USD 1,088 million in 2025, is projected to reach USD 1,195 million in 2026 and USD 2,902 million by 2035, with a 10.4% CAGR during the forecast period 2026 to 2035. The current market landscape features the presence of over 170 companies providing antibody conjugation services and 120 companies providing service for protein labeling, spread across the globe. Further, it is worth highlighting that, since 2018, over 70 strategic partne...

The global bispecific antibodies market, valued at USD 8.93 billion in 2025, is projected to reach USD 8.78 billion in 2026 and USD 16.81 billion by 2035, with a 7.5% CAGR during the forecast period 2026 to 2035. Bispecific antibodies (BsAbs) represent a novel class of antibodies that act by simultaneously attaching to two separate / distinct antigens or different epitopes of the same antigen. It is worth mentioning that, till date, 15 bispecific antibodies have been approved for therapeutic use...

As per recent studies, the annual burden of oncological disorders is more than USD 185 billion in the US. In order to address the aforementioned challenge, various developers across the globe, have identified inhibition of enhancer of zeste homolog 2 (EZH2) as one of the potential target mechanisms. Over the years, inhibition of the EZH2 gene has been validated across various studies to suppress the growth of cancer cells. Notably, the first EZH2 inhibitor, Tazemetostat was approved by the USFDA...

The global DNA encoded library market is estimated to grow from USD 1.2 billion in 2025 to reach USD 1.3 billion in 2026 and USD 5.0 billion by 2035, representing a higher CAGR of 16.3% during the forecast period 2026 to 2035. The growing adoption of DNA encoded chemical libraries by pharmaceutical and biotechnology companies, academic institutions and contract research organizations has further propelled the market growth of this industry. Driven by the ongoing pace of innovation in this field...

The global viral clearance market valued at USD 615 million in 2025, is project to reach USD 664 million in 2026 and USD 1,704 million by 2035, representing a higher CAGR of 11.0% during the forecast period 2026 to 2035. In terms of scale of operation, the clinical segment holds the highest share (more than 85%) of the market. With regards to method of viral clearance and testing, the viral removal segment dominates the global market with 55% market share. Based on the end users, the contract re...

Tissue injury and dysfunctioning commonly occurs in humans; however, not in all cases, the tissue regeneration capability of a human body is able to cope up with the damage caused. o improve on this aspect, additive manufacturing, specifically 3D bioprinting, is being explored in the tissue engineering domain. The 3D bioprinting technique employs bioinks (consisting of living cells and biomaterials) to fabricate complex anatomical structures (tissues, cartilages and organs), in a layer-by-layer...

The global monkeypox treatment market size is estimated to shrink from USD 86 million in 2026 to USD 4.8 million by 2035, representing a CAGR of (-)27.4% during the forecast period 2026 to 2035. In May 2022, multiple cases of the disease were reported in several non-endemic countries, thereby making monkeypox a disease of global concern. In fact, till date, over 71,000 cases of the disease have been reported, globally. In response to the monkeypox outbreak, active research and development effort...

The global exosome therapy market is estimated to grow from USD 32 million in 2029 to reach USD 382 million in 2035 and USD 1,405 million by 2040, representing a higher CAGR of 41.1% during the forecast period. In recent years, therapies utilizing extracellular vesicles have garnered significant attention among the industry stakeholders for the treatment of diverse indications, primarily owing to the various benefits offered by them, including target specificity, enhanced tissue regeneration, an...

Over the last 2 decades, gene editing concepts and genetic engineering have evolved significantly, with the development of a variety of versatile DNA modulation technologies, including clustered, regularly interspaced short palindromic repeats (CRISPR), zinc finger nucleases and transcription activator-like effector-based nucleases (TALENs). CRISPR / Cas system is a powerful tool with a wide array of applications in the field of disease treatment and diagnosis, and agriculture and biotechnology....

The global protein engineering market, valued at USD 0.85 billion in 2025, is projected to reach USD 0.96 billion in 2026 and USD 3.15 billion by 2035, with a 14.1% CAGR during the forecast period 2026 to 2035. Driven by the significance offered by protein-based medications, several pharmaceutical companies accelerated their research efforts towards development of novel medicines. It is worth highlighting here that more than 55 protein-based therapies have already been marketed for the treatm...

The tissue engineering market, valued at USD 4.6 billion in 2025, is projected to reach USD 4.9 billion in 2026 and USD 12.7 billion by 2035, with a 11.2% CAGR during the forecast period 2026 to 2035. Over the years, there has been an increase in accidental injuries and diseases that result in tissue or organ damage. According to a research report, nearly 6% of individuals are projected to be affected by chronics wounds across the globe. To address the concern, regenerative medicine and tissue e...

Microbiome refers to the diverse community of microorganisms that inhibit different environments in and on the human body (such as gut, respiratory tract, skin and urogenital tract). In fact, the human microbiome contains about 100 trillion microbes. However, the imbalances in microbiota, also known as dysbiosis, often results in negative health consequences including (but not limited to) anxiety, autism, cancer, diabetes, infectious diseases, inflammatory bowel diseases and obesity. In the abov...

The global in vitro ADME toxicology testing market, valued at USD 4.5 billion in 2025, is projected to reach USD 5.2 billion in 2026 and USD 6.0 billion by 2030, with a 3.9% CAGR during the forecast period 2026 to 2030. The need for improved therapeutic drugs to target a wide range of diseases has heightened the focus on ADME toxicology testing to ensure the efficiency and safety of medicines for human use. Currently, oncology disorders are likely to hold the largest share of the market and are...

The oral proteins and peptides market, valued at USD 2.47 billion in 2025, is projected to grow to USD 3.26 billion in 2026 and USD 8.42 billion by 2032, representing a CAGR of 17.1% during the forecast period. The growth of the oral proteins and peptides market is mainly driven by the rising prevalence of chronic diseases such as diabetes, chronic idiopathic constipation, and others. These chronic diseases require daily dose of medicine, sometime multiple dose in a day. Owing to the large size...

The liposome manufacturing market, valued at USD 0.9 billion in 2025, is projected to grow to USD 1.0 billion in 2026 and USD 2.3 billion by 2035, representing a CAGR of 10.1% during the forecast period. Liposome manufacturing involves the production of liposomes, which are small artificial vesicles composed of lipid bilayers. These vesicles are capable of encapsulating drugs or other active molecules within their structure which allow targeted delivery to specific sites within the body. The mar...

The vaccine adjuvants market, valued at USD 5.26 billion in 2025, is projected to grow to USD 5.51 billion in 2026 and USD 6.08 billion by 2035, representing a CAGR of 1.1% during the forecast period. Presently, an increasing number of vaccines under development are incorporating adjuvants in vaccines owing to various advantages offered by such agents, including improved adaptive response to a vaccine, guiding the type of adaptive response to produce the most effective forms of immunity for each...

The global molecular cloning market for kits is estimated to grow from $3.1 billion in 2025 to $3.6 billion in 2026 and $14.5 billion by 2035, representing a higher CAGR of 16.9% during the forecast period. Further, more than 3,200 patents and 4,000 research articles have been published for DNA cloning technologies in the past few years; this is indicative of the innovative efforts of the stakeholders engaged in molecular cloning market. Driven by the increasing demand for gene therapies and the...